Trials / Completed
CompletedNCT01519063
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
Glutamate-opioid Interactions in Alcohol Drinking Behaviors
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the combined effects of the study medications naltrexone and memantine on alcohol drinking behaviors.
Detailed description
Participants will be randomized to receive a combination of naltrexone/memantine over a one week period and then participate in a laboratory session. During this session, participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. These medications are hypothesized to reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naltrexone and memantine first | Naltrexone 50mg memantine 20mg |
| DRUG | Naltrexone and Placebo first | Naltrexone 50 mg Placebo |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2017-03-29
- Completion
- 2017-05-01
- First posted
- 2012-01-26
- Last updated
- 2020-03-09
- Results posted
- 2019-07-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01519063. Inclusion in this directory is not an endorsement.